Zbornik Matice srpske za prirodne nauke 2011 Issue 121, Pages: 19-26
doi:10.2298/ZMSPN1121019J
Full text ( 215 KB)


Susceptibility to antifungal agents of Candida spp. from blood and feces collected in Novi Sad in 3-year period (2008-2010)

Jelesić Zora Z., Medić Deana D., Mihajlović-Ukropina Mira M., Jevtić Marija, Gusman Vera P., Radosavljević Biljana J., Milosavljević Biljana T.

Candidemia is an important emerging nosocomial infection in patients with risk factors. Candida species from nonsterile sites can give insight into the characteristics of strains that may cause invasive disease. The aim of this study was to evaluate antifungal susceptibility of Candida blood and fecal isolates in Novi Sad, Vojvodina. During a 3-year period (2008 to 2010), 424 isolates of Candida spp. were collected, 30 bloodstream isolates and 394 strains from fecal samples. In vitro susceptibility of these isolates to five antifungal agents was established using commercial ATB FUNGUS 3 (Bio-Mérieux). Predominant species was Candida albicans (6 isolates from blood and 269 from feces). Resistance to one or more antifungal agents was less common in Candida albicans (3.63%) than in other species (24.83%). Resistance to itraconazole was the most commonly found in both groups of isolates, 9.64% strains from feces and 20% from blood samples. Twelve isolates were multiply resistant, usually to fluconazole, itraconazole, and voriconazole. Resistance to amphotericine B was extremely rare. Although resistance to antimycotics of Candida spp. is rare at present, continued surveillance of antifungal susceptibility is necessary in order to monitor trends, and to choose the right empiric therapy.

Keywords: antifungal susceptibility, candidemia, Candida spp.